Novavax Covid-19 shot shows 90% efficacy, Serum Institute starts production
US primarily based Novavax on Monday claimed that its nano-particle protein primarily based Covid-19 vaccine
US primarily based Novavax on Monday claimed that its nano-particle protein primarily based Covid-19 vaccine